The startup develops injectable scaffolds and foams that mimic the extracellular matrix to promote tissue repair and remodeling at the injection site. Their products provide healthcare professionals with effective tools to enhance the body's natural healing processes in various medical applications.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for tissue repair often lack the structural support necessary for effective cell growth and regeneration, leading to incomplete or delayed healing, particularly in complex tissue structures. Existing solutions may not adequately address the multi-layered nature of tissue damage, failing to promote comprehensive restoration across all affected areas.
Solution
BioChange offers CellFoam™ technology, a natural protein foam scaffold designed to create a three-dimensional environment that supports cell growth and facilitates tissue repair. This biocompatible and biodegradable matrix mimics the extracellular environment, encouraging natural tissue regeneration and reversing deterioration in damaged areas. The CellFoam™ scaffold degrades naturally within approximately three months, while the tissue repair effect lasts considerably longer. BioChange's technology is currently available for veterinary use and is progressing towards human clinical trials, initially targeting periodontitis.
Target Audience
The primary customers are veterinarians seeking advanced solutions for tissue regeneration and repair in animals, as well as healthcare professionals in the human sector focused on periodontitis treatment.
Features
- CellFoam™ technology: A crosslinked gelatin foam providing a porous, three-dimensional structure for cell growth.
- ReGum™ Vet: A scaffold for guided tissue repair in dogs with periodontitis, available in conic and flat square shapes.
- VetFoam™: An injectable scaffold for treating urinary incontinence in female dogs, demonstrating high success rates in clinical studies.
- vitaloc™: A powder mix of gelatin and crosslinking enzyme for controlling bleeding during oral surgical procedures.
- Customizable shapes and sizes for various applications, including plugs, blocks, and cones.
- Demonstrated safety and efficacy in long-term animal studies.